NKTR News

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Nektar Therapeutics Investors to Secure Counsel Before Important Deadline in Securities Class Action - NKTR

NKTR Investors Have Opportunity to Lead Nektar Therapeutics Securities Fraud Lawsuit with the Schall Law Firm

Pomerantz LLP Announces Class Action Filing Against Nektar Therapeutics – NKTR

Pomerantz LLP Announces Class Action Litigation Filing Against Nektar Therapeutics – NKTR

NKTR INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Nektar Therapeutics Shareholders Have Opportunity to Lead Class Action Lawsuit!

Pomerantz LLP Announces Class Action Against Nektar Therapeutics – NKTR

Pomerantz LLP Announces Class Action Litigation Against Nektar Therapeutics – NKTR

ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Nektar Therapeutics Investors to Secure Counsel Before Important Deadline in Securities Class Action - NKTR

RGNX SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds REGENXBIO (RGNX) Investors of Securities Class Action Deadline on April 14, 2026 Ready to Announce with Confidence?

RR SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds Richtech Robotics (RR) Investors of Securities Class Action Deadline on April 3, 2026 Ready to Announce with Confidence?